Clinical and immunological status of a newly diagnosed HIV positive population, in Marrakech, Morocco

African Health Sciences

Volumn 10, Issue 4, 2010, Pages 325-331

  Admou, B ^a   Elharti, E ^b   Oumzil, H ^b   Addebbous, A ^a   Amine, M ^c   Zahlane, K ^a   Soraa, N ^a   Zougaghi, L ^a   Haouach, K ^a   Tassi, N ^d   Aajly, L ^e   Chabaa, L ^a   El Aouad, R ^b  

^a CHU Mohammed VI   (Morocco)

^b INSTITUT NATIONAL D HYGIÈNE   (Morocco)

^c University Cadi Ayyad Faculte de Medecine et de Pharmacie de Marrakech   (Morocco)

^d University Hospital of Marrakech   (Morocco)

^e Ibn Zohr Hospital   (Morocco)

Author keywords

CD4T cells count; CDC classification; HIV infection; Marrakech; Morocco

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DELAYED DIAGNOSIS; DISEASE CLASSIFICATION; FEMALE; FLOW CYTOMETRY; HIGH RISK POPULATION; HIV EDUCATION; HIV TEST; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; MAJOR CLINICAL STUDY; MALE; MOROCCO; OPPORTUNISTIC INFECTION; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DELAYED DIAGNOSIS; DELIVERY OF HEALTH CARE; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MOROCCO; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 79952306249     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Gupta SB, Gilbert R.L, Brady AR, Livingstone SJ, Evans BG. CD4 cell counts in adults with newly diagnosed HIV infection: results of surveillance in England and Wales, 1990-1998. AIDS 2000 May; 14(7): 853-61.
2. Lelièvre JD, Arnoult D, Petit F, Estaquier J. Infection par le VIH-1 et apoptose lymphocytaire T CD4. La revue de Médecine interne 2003; 24: 522-9.
3. Garrait V., Molina J.M. Nouvelles stratégies de traitement anti-rétroviral chez les patients infectés par le VIH. Pathol Biol 2001; 49: 67-71.
4. Napolitano. Approach to immune reconstitution in HIV infection. Perspective. International AIDS Society-USA 2003 September/October; 11(5):160-6.
5. Mallal SA. The Western Australian HIV Cohort Study, Perth, Australia. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 17 Suppl. 1: 23-7.
6. Moore RD and Chaisson RE. Natural History of Opportunistic Disease in an HIV-Infected Urban Clinical Cohort. Annals of Internal Medicine 1996 April; 124(7): 633-42.
7. Lesprit Ph et Molina J-M. La co-infection VIHtuberculose: causes et conséquences Méd Mal Infect 1996; 26: 918-21.
8. Morlat PH, Ragnaud JM, Gin H, Lacoste D, Beylot J and Aubertin J. La toxoplasmose cérébrale au cours du SIDA. Médecine et Maladies Infectieuses 1993 Février;23 Suppl 1:183-9
9. May T, Rabaud C, Katlama C, Leport C, Ambroise-Thomas P, Canton Ph. and le groupe d.étude. Toxoplasmose extra-cérébrale au cours du SIDA: résultats d.une enquête nationale Médecine et Maladies Infectieuses 1993 February; 23, Suppl 1:190-200.
10. Lafeuillade A, Poizot-Martin I, Boulat O, Allegre T, de Jaureguiberry JP, le Groupe D. Etudes en Médecine Interne de Provence (GEMIP). Le sarcome de Kaposi de présentation extracutanée au cours du SIDA: 24 observations. Médecine et Maladies Infectieuses 1994 February; 24(2): 92-95.
11. Karkouri M. L.infection à VIH au Maroc. Annales de pathologie (2008) 28S, 113
12. Castro K-G, Ward J-W, Slutsker L, Buehler JW, Jaffe H-W, Berkelman R-L. 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. Recommendations and reports. http://www.cdc.gov.
13. WHO. Proposed WHO criteria for interpreting results from Western blot assays for HIV-1 and HIV-2 and for HTLV-I /HTLV-II Weekly epidemiological record 1990; 65(35): 281-83.
14. Stein D.S., Korvick J.A., Vermund S.H. CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. J Infect Dis.1992; 165(2):352-63.
15. Soogoor M, Daar ES. Primary HIV-1 Infection: Diagnosis, Pathogenesis, and Treatment. Curr Infect Dis Rep. 2005 Mar; 7(2):147-53.
16. Douek D, HIV Disease Progression: Immune Activation, Microbes, and a Leaky Gut. International AIDS Society.USA Topics in HIV Medicine 2007; 15 (4):114-17.
17. Centlivre M, Sala M, Wain-Hobson S, Berkhout B. In HIV-1 pathogenesis the die is cast during primary infection. AIDS 2007; 21:1.11.
18. Diagbouga S, Chiron JP, Sanou O, Ledru E. Alteration in CD29high CD41 Lymphocyte Subset is a Common Feature of Early HIV Disease and of Active Tuberculosis. Scand. J. Immunol. 2001; 53: 79-84.
19. Sterling TR, Chaisson RE, Keruly J, Moore RD. Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus infected patients who achieve durable virologic infpression: longer follow-up of an observational cohort study. J Infect Dis. 2003; 188(11):1659.65.
20. Plan stratégique national de lutte contre le Sida 2007-2011, DELM. Ministère de la Santé, Royaume du Maroc. www.sante.gov.ma
21. Zannou D.M., Kindé-Gazard D., Vigana J., Adè G., Sèhonou J.J., Atadokpèdé F., Azondékon A., Gbèdo C., Anagonou S.Y. and Houngbé F. Profil clinique et immunologique des patients infectés par le VIH dépistés à Cotonou, Bénin. Médecine et Maladies Infectieuses 2004 May; 34(5): 225-228.
22. Fonquernie L, Dray-Spira R., Bamogo E, Lert F. and Girard P.M. Caractéristiques des patients nouvellement pris en charge pour une infection VIH dans un CHU parisien en 2002.2003. Médecine et Maladies Infectieuses 2006 May; 36(5): 270-279.
23. Boyd AE, Murad S, Oshea S, de Ruiter A, Watson C., Easterbrook P.J. Ethnic differences in stage of presentation of adults newly diagnosed with HIV-1 infection in south London. HIV Med. 2005 Mar; 6(2):59-65.
24. Doco-Lecompte T, Yazdanpanah Y., Fischer P., Froidure M., Douadi Y., Strady C., Chirouze C., Rabaud C. Infections à VIH nouvellement découvertes dans le nord et le nord-est de la France: données 2000 et 2001. Médecine et maladies infectieuses 2003;33:304-8.
25. Wannamethee SG, Sirivichayakul S, Phillips AN, Ubolyam S, Ruxrungtham K, Hanvanich M, Phanuphak P. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand. International Journal of Epidemiology 1998; 27:289-95.
26. Ruxrungtham K., Phanuphak P. Update on HIV/AIDS in Thailand. J Med Assoc Thai 2001 Jun; 84 Suppl1:11-17.
27. Elharti E, Alami M, Khattabi H, Bennani A, Zidouh A, Benjouad A, El Aouad R Some characteristics of the HIV epidemic in Morocco. East Mediterr Health J. 2002 Nov;8(6):819-25.
28. Papathanasopoulos M-A, Hunt G-M. and Tiemessen C-T. Evolution and Diversity of HIV- in Africa. a Review. Virus Genes 2003 March; 26(2): 151-63